Concept Dha Capsule, Liquid Filled
Pricing Report NDC 52747-621-30

Current NADAC: $1.16100 per EA · Effective Oct 01, 2026 · Est. package price $34.83 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Concept Dha (NDC 52747-621-30) is $1.16100 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 01, 2026.

As a a human prescription drug provided by U.s. Pharmaceutical Corporation, this medication is distributed in a 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.16100
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Oct 01, 2026
Billable Units
30 EA
Estimated Package Price
$34.83
Data Status
As of Oct 07, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
52747-621-30
Description
30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.90507 to $1.16100 per EA. Over this 12 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.9051 - $1.1610
Market Volatility
28.28% Variance
Latest Trend
10.01%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 01, 2026 $1.16100 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Sep 23, 2026 $1.05537 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $1.05942 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $1.05819 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $1.05480 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 20, 2026 $1.05550 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 22, 2026 $1.05600 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 18, 2026 $1.05867 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 18, 2026 $1.05888 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 21, 2026 $1.05888 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 17, 2025 $1.05888 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2020 $0.97324 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026